← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Window Therapeutics, Inc.
Boston, MA
$1,555,999
Total funding
3
Grants
Funding over time
peak $1M · FY2022–25$1M$750K$500K$250K$0
'22
'23
'24
'25
Funding mix
By agency
NSF$1,256,000 · 2
NIH$299,999 · 1
By mechanism
—$1,256,000 · 2
R43$299,999 · 1
Investigators at Window Therapeutics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
SBIR Phase II: Antibody-Drug Conjugates (ADCs) with High Drug-Antibody Ratios (DAR) and Molecularly Targeted Payloads$1,000,000
· FY2025 · TIP
Proteasome Inhibitor-Loaded Antibody Drug Conjugates with High Drug Loading For Targeted Treatment of Triple Negative Breast Cancers$299,999
R43 · FY2023 · CA
SBIR Phase I: Antibody Brush Polymer Conjugates with High Drug Antibody Ratios and Immunostimulatory Payloads for Treatment of Late-Stage Cancers$256,000
· FY2022 · TIP